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INTRODUCTION 
 
Antimicrobial resistance is one of the most serious health threats. Infections caused by 
resistant bacteria are emerging, and some pathogens have even become resistant to multiple 
classes of antibiotics. The latest report of the Centers for Disease Control and Prevention (CDC) 
sounded the alarm to the dangers of antibiotic resistance, stating that each year in the U.S. at 
least 2 million people suffer from an antibiotic-resistant infection, and more than 23,000 people 
die. 
Enterococci cause a range of diseases such as sepsis, wound and urinary tract infections, 
especially among patients receiving medical care. 30% of healthcare-associated enterococcal 
infections are vancomycin-resistant. The clinically relevant species are: Enterococcus faecalis, 
Enterococcus faecium, E. gallinarum and E. casseliflavus. According to the CDC, 77% of VRE 
infections are caused by Enterococcus faecium and 9% by Enterococcus faecalis. The latest 
data of the European Centre for Disease Prevention and Control (ECDC) showed that the 
prevalence of VRE E. faecium (VREfm) has been steadily increasing among Hungarian 
hospitalized patients. This report demonstrated a rise from 0,8% to 39,5% among invasive 
isolates in Hungary between 2011 and 2018. 
Concerning the epidemiology of VRE, we know that the appearance and spread of these 
strains has a different background in Europe and in the United States. While in the USA the 
widespread usage of vancomycin and/or cephalosporin in human treatment, in Europe, the 
application of avoparcin as a growth-promoting factor in animal husbandry lead to the 
appearance of VRE. Enterococci are ubiquitous in gastrointestinal tracts even though they 
constitute a small proportion approx. 0.01% of the normal bowel flora. Typical concentrations 
in stool are up to 108 Colony Forming Unit (CFU)/gram in humans. A number of risk factors 
have been associated with VRE colonization. These include prolonged hospital stay, advanced 
age, severe underlying disease, central venous catheterization and exposure to various 
antibiotics such as vancomycin or metronidazole. Asymptomatic carriage of VRE and the lack 
of effective decolonization regimen stabilize their endemicity in the healthcare settings. This 
colonization may serve as a reservoir for the transmission to other patients resulting in increased 
morbidity, mortality and cost.  
Under these circumstances the significance of resistance surveillance has rised. 
Monitoring the presence of resistant strains, and identifying potential reservoirs is essential for 
determining appropriate empirical antibiotic therapy. With my research work I wanted to 
contribute to this area by analyzing vancomycin-resistant enterococci at the Bacteriological 
Diagnostic Laboratory of the Department of Medical Microbiology. 
  
   
AIMS 
 
The goal of my work was the epidemiological and molecular characterization of VRE 
isolated from clinical samples and to determine the carriage rates of VRE from stool samples. 
We also investigated various risk factors which could be associated with VRE colonization. 
 
Investigation of vancomycin-resistant enterococcus strains isolated from clinical 
specimens: 
Aims:  
1. Screening of VRE strains isolated from clinical samples collected between 2012-
2015. 
2. Identification of VRE using MALDI-TOF MS (Matrix-Assisted-Laser-Desorption 
and Ionization Time-of-Flight Mass Spectrometry). 
3. Antibiotic susceptibility testing, and molecular identification of antibiotic resistance 
and virulence genes. 
4. Investigating the association between virulence factors and biofilm formation. 
5. Investigating the epidemiological relationships between the isolates by pulsed field 
gel electrophoresis (PFGE) and multilocus sequence typing (MLST).  
 
 
Investigation of vancomycin-resistant enterococcus strains isolated from stool: 
Aims: 
1. Screening of VRE strains isolated from stool samples collected between February 
and September 2016 by using two screening methods. 
2. Identification of VRE by MALDI-TOF MS. 
3. Antibiotic susceptibility testing and molecular identification of the resistance genes. 
4. Characterization of VRE positive patients and carriers. 
5. Analysis of risk factors for VRE colonization. 
  
   
MATERIALS AND METHODS 
 
Isolates 
Clinical samples were collected between January 2012 and December 2015. Isolates 
were cultured on VRE screening plates containing 6 µg/mL vancomycin. The period of the 
stool sample examination was divided into two phases. In the 1st period (155 days, 2050 
specimens) stools were inoculated with a glass stick onto solid VRE screening medium 
containing 6µg/mL vancomycin. In the 2nd period (88 days, 971 specimens) the same 
inoculation technique and culture medium was used but without solidification with agar (broth 
enrichment). 
 
Antimicrobial susceptibility testing 
All protocols were performed according to the manufacturer’s instructions. The 
European Committee on Antimicrobial Susceptibility Testing guidelines were used to interpret 
the results. Determination of antibiotic susceptibility patterns was performed by Kirby-Bauer 
disc diffusion using ampicillin (2µg), gentamicin (30µg) and ciprofloxacin (5µg) antibiotic 
discs. E-test is the most appropriate method for determining MIC values in the routine 
diagnosis. On the surface of the E-test strips there are well defined concentration gradients of 
antibiotics. After the appropriate incubation period an elliptical growth inhibition zone will 
develop. Vancomycin, teicoplanin, daptomycin, tedizolid, linezolid, tigecyline and 
quinupristin/dalfopristin minimum inhibitory concentrations (MICs) were determined by E-
test. 
 
 
Molecular biology techniques 
 
Polimerase chain reaction 
Templates of the PCR reactions were bacterial lysates prepared by the boiling method 
of Yean and colleagues (2007). PCR conditions and primers for the VanA, VanB, VanC, VanD, 
VanE, and VanG resistance genes as well as for E. faecalis and E. faecium D-alanine:D-alanine 
ligase (ddl) were taken from Depardieu et al (2004). The oligonucleotide primers used in 
virulence gene (agg, ace esp) detections were described previously by Woodford et al., Eaton 
et al., and Mannu et al. PCR reactions were performed according to Cariolato and colleagues 
(2008). Primers for the MLST experiments were used according to the https://pubmlst.org/ 
website. The results of the PCR reactions and were determined by agarose gel electrophoresis. 
 
Testing biofilm formation 
To study the biofilm forming ability of the VRE strains a modified microtiter-plate test 
was performed based on the protocol of Stepanovic et al. (2007) with some modifications. This 
method is superior to the standard test because it measures bacteria attached both to the bottom 
and walls of ELISA plates. The optical density (OD) was measured photometrically at 
540/620nm. The optical density cut-off (ODc) was defined as the standard deviations above the 
mean OD of the negative control. Isolates were classified as follows: OD ≤ ODc = no biofilm 
producer, ODc < OD ≤ 2 × ODc = weak biofilm producer, 2 × ODc < OD ≤ 4× ODc = moderate 
biofilm producer, 4 × ODc < OD= strong biofilm producer.   
 
 
 
 
 
   
Methods of epidemiological typing 
 
Pulsed-field Gel Electrophoresis (PFGE) 
PFGE of VRE strains was performed according to the protocol of Murray et al. and 
McEllistrem et al. at the National Public Health Center, with slight modifications. PFGE-
generated DNA profiles were entered into the Fingerprinting II.version 3.0 Software using 1.0% 
position tolerance and 1.0% optimization setting. The quantitative differences among the 
banding patterns were defined by the Dice coefficient. Unweighted pair group method with 
arithmetic mean (UPGMA) was used for cluster analysis of the PFGE patterns. 
 
Multilocus sequence typing (MLST) 
Internal fragments of seven housekeeping genes (adk, atpA, ddl, gdh, gyd, purK and 
pstS) were amplified by PCR and were sequenced. Allele numbers for each loci were given 
according to the E. faecium MLST database (http://www.pubmlst.org/efaecium/).  The 
combination of the allelic sequences for the seven genes yielded the allelic profile for each 
isolate. The goeBURST 1.2.1. algorithm was used for clustering the determined sequence types. 
 
 
Epidemiological data analysis 
Medical records of patients with VRE positive fecal samples were investigated 6 months 
prior screening for the following factors: age, sex, underlying disease, length of hospitalization, 
antibiotic consumption, intravenous catheter, dialysis, nasogastric tube, tracheostomy, 
ventilator use, absence of normal enteric flora and presence of toxin positive Clostridioides 
difficile. We analyzed our database (MedBakter) for any other VRE positive clinical specimen 
of the carriers 6 months preceding and following our screening. For statistical analysis we 
investigated 93 VRE negative fecal samples; patients in this population were selected by 
Monte-Carlo simulation based on random number generation.  
Medical data was evaluated with the SPSS software version 24.0 (SPSS Inc.). The 
outcome of colonization with VRE was expressed as binary categorical variable. All categorical 
variables were analyzed by Chi-square test. If all expected value frequencies were not equal to 
or greater than 5, Fisher exact probability test was used while logistic regression was used for 
continuous independent variables and categorical outcome. P-value less than 0.05 was 
considered statistically significant. Additionally, odds ratio was used to determine the 
association between risk factors and VRE colonization. 
 
Analysis of the association between Esp and biofilm formation 
Chi-square (χ2) significance test was carried out to investigate the association between 
the presence of the esp gene and biofilm positivity; p-value≤0.05 was considered statistically 
significant. Contingency table analysis was used to infer whether the presence of the esp gene 
is correlated with biofilm formation. Additionaly we used odds ratio test to determine the 
chance of biofilm production if the esp gene is present. Evaluation of data was performed with 
the SPSS software version 24.0 (SPSS Inc.). 
  
  
   
 
RESULTS 
 
Characterization of VRE strains isolated from clinical samples 
During the 4-year research period a total of 7799 Enterococcus spp. were recovered 
from various clinical samples. Among all enterococci 73 grew on the VRE screening plates 
originating from 43 patients. Identification with the MALDI-TOF MS revealed that all VRE 
were Enterococcus faecium (VREfm) with high score values (>2.0). The majority of VREfm 
were recovered from wound/decubitus (26%) followed by urine (23.3%), blood and cannula 
(14-14%). The mean patient age was 57 years with almost equal gender distribution (males: 
51.2%, females: 48.8%). 
 
Results of antibiotic susceptibility testing 
All isolates showed resistance to vancomycin, ampicillin and ciprofloxacin, followed 
by gentamicin (81.4%). 7% of the strains showed resistance to teicoplanin. All of them were 
susceptible to newer antibiotics such as linezolid, tedizolid, tigecyclin and daptomycin. 
 
Detection of vancomycin resistance genes and virulence factors 
Among the 43 VREfm isolates 40 harboured the vanB (93%) and 3 the vanA (7%) gene. 
The gene coding for the Esp protein was present in 7 (16.3%) isolates which were obtained 
from various invasive and non-invasive body sites such as blood, cannula, cerebrospinal fluid, 
bronchial washing, sputum, urine and decubitus. None of the isolates yielded a PCR product 
with the vanC, vanD, vanE, vanG, ace or agg specific primers. 
 
Results of biofilm formation 
40% of the isolates were biofilm producers.  Of the 43 isolates none proved to be strong 
biofilm producer. Out of the 17 isolates that formed biofilm only 4 (24%) produced biofilm 
moderately while 13 (76%) were weak biofilm producers. According to the origin of the 
samples among the invasive 71.4% (5/7) while from the non-invasive 33.3% (12/36) produced 
biofilm. Based on the Chi-square test there was no statistically significant correlation between 
biofilm production and isolation site. Correlation was found between the presence of the esp 
gene and biofilm production (p=0.059) with 90% confidence. The contingency table analysis 
showed a weak relationship (C=0.28). According to the odds ratio test the chance of biofilm 
positivity is five times higher if esp is present. Two isolates encoded esp but did not form 
biofilm, while twelve isolates were biofilm producers with no virulence genes detected. 
 
Results of epidemiological analysis 
At the beginning of the study (2012 and 2013) all VRE were tested, from 2014 PFGE 
was restricted to all of the vanA positive isolates as well as to invasive samples. PFGE analysis 
revealed 9 PFGE types based on a similarity cut off value of ≥ 85%. The predominant pulsotype 
was ENTCO-062 and included 11 (vanB) isolates followed by ENTCO-075 (3 vanB, 1 vanA 
isolates) and ENTCO-151 (2 vanA isolates). 6 additional PFGE types were represented by a 
single isolate each. 
MLST analysis was performed from 14 VREfm isolates and revealed 6 different 
sequence types. The predominant ST in this study was ST17 (6 vanB isolates). Less frequent 
types were ST117 (2 vanA, 1 vanB), ST203 (2 vanA), ST78 (1 vanB), ST412 (1 vanB) and 
ST364 (1 vanB). All could be assigned to the clonal complex 17 (CC17), a specific lineage 
associated with nosocomial E. faecium strains. 
 
 
   
Characterization of VRE strains isolated from stool samples 
During the first research period a total of 2050 samples were screened by solid screen. 
313 samples yielded black colonies on the screen agar. However, only 266 isolates were 
selected based on their colony morphology on blood agar for MALDI-TOF measurements. In 
the second research period 971 samples were screened with enrichment broth. Among them 
469 caused blackening of the broth and according to their macroscopic morphology 264 isolates 
were selected for MALDI-TOF analysis.  
Altogether a total of 102 non-duplicate VRE were obtained from 93 patients. 
Identification with the mass spectrometer revealed that 71 VRE were E. faecium, the second 
most common species was E. gallinarum (n=23) followed by 5 E. faecalis, 2 E. casseliflavus 
and 1 E. hirae. Among the E. faecium isolates 33 were vanA and 38 were vanB positive. Only 
4 vanA and 1 vanB positive E. faecalis were detected. The single E. hirae was found to be vanA 
positive. All E. gallinarum carried the VanC1 and E. casseliflavus the VanC2 genes.  
VanB positive isolates showed high level resistance against vancomycin and sensitivity 
to teicoplanin whereas the vanA positive isolates displayed high level resistance against both 
antibiotics. All of the vanC strains had low level vancomycin resistance and were susceptible 
to teicoplanin. Fortunately, all isolates were susceptible to newer antibiotics such as linezolid, 
tigecycline and daptomycin. Quinupristin/dalfopristin resistance was found only in 4 E. faecalis 
isolates. 
 
Epidemiological features of VRE carriers 
VRE carrier’s mean age was 47 years. The mean length of hospital stay prior screening 
was 25 days. The most prevalent underlying disease was malignancy (22.6%) followed by 
diabetes and viral or bacterial infection (21.5%). Among the investigated risk factors absence 
of normal enteric flora was found in 24.7%. 18 carriers (19.4%) had toxin positive C. difficile 
detected at least once at the time of screening or in the previous 6 months.  
Statistical analysis of 93 colonized and non-colonized patients showed that diabetes, 
normal flora absence, C. difficile positivity, longer hospital stay and advanced age were 
significantly associated with VRE colonization. The highest chance occured in case of diabetes. 
The chance of VRE positivity was 12.46 times higher in these patients. 78.5% of the VRE 
colonized patients received at least one kind of antibiotic during the 6 months prior stool 
sampling. Among them metronidazole was the most commonly administered (47.3%) followed 
by cephalosporins (40.9%). 
 
Characterization of screening methods 
In the first period of investigation the solid screening medium detected 46 VRE (2.2%) 
from 2050 stool samples while in the second period broth enrichment identified 56 VRE (5.8%) 
from 971 stools. Interestingly, 1 vancomycin resistant E. hirae was also identified in the second 
period. 
  
 
  
   
DISCUSSION 
 
Previously our research group assessed the prevalence of VRE between 2004 and 2009 
at the teaching hospitals of the University of Debrecen and found the predominance of VanC 
positive E. gallinarum and E. casseliflavus strains. Since then the picture has changed. Recent 
data from the ECDC revealed a significant increase of invasive VREfm between 2012 and 2018. 
In accordance with the national trends we observed the elevation of invasive and non-invasive 
VREfm from 1.7% to 11% at our teaching hospital. 
Fortunately, the newest antibiotics were the most effective agents against our isolates. 
The gene coding Ace did not occur in any of the tested strains. This is in agreement with 
previous findings of other research groups who found ace only in E. faecalis. Similarly, none 
of the tested VREfm isolates harbored the gene for Agg in correlation with earlier reports. In 
our study, esp was the only virulence factor found in 16.3% of the strains. Several previous 
studies have presented that esp is a signal for widely disseminated hospital clones of antibiotic-
resistant E. faecium.  
Our research group evaluated biofilm formation and its relationship with virulence 
genes in E. faecium. Association between the presence of the esp gene and biofilm positivity 
was weak. When esp is present in the strain the chance of biofilm positivity is five times higher. 
However, biofilm formation may rely on several different mechanisms independent of esp. 
PFGE analysis showed 9 different pulsotypes. 74% of the strains could be grouped into 
3 main clusters (ENTCO-062, ENTCO-075, ENTCO-151) indicating monoclonality. At the 
beginning of our survey ENTCO-062 pulsotype predominated but it was still present in 2014 
and 2015 to a lesser extent. Although 5 isolates showed 100% similarity within this cluster 
(with ST17 and vanB genotype) these proved to be sporadic cases. At the end of the examination 
period rising prevalence of ENTCO-075 pulsotype was documented. 
 By MLST 14 VREfm isolates could be assigned to six STs all belonging to clonal 
complex 17 and four of them (ST17, ST117, ST78, ST203) representing major ampicillin-
resistant hospital-derived clones. Our research group was the first who described the VREfm 
isolates belonging to ST412 and ST364 sequence types in the Central European region. An 
interesting finding was the detection of ST364. To our knowledge this ST was first reported by 
Zhu X et al. from Beijing, China and only one isolate was reported from Taiwan. Until now no 
other strain of this type has been deposited to the E. faecium MLST database 
(http://www.pubmlst.org/efaecium/) from Eastern-Europe. ST412 has yet been found in several 
countries, mainly from the Americas and Western Europe. Interestingly, two isolates arose from 
blood with the same ST (ST117) and both were negative for esp but one was VanA and the other 
VanB positive. Further analysis revealed that isolation time of the two strains was very close 
(within 5-days) but they were from different Departments. In these cases acquisition of either 
vanA or vanB gene clusters might have occurred in two different occasions. 
Up till now there has been no information on fecal colonization rates with VRE of 
patients admitted to our hospital, despite the fact that carriers can serve as source of nosocomial 
infections. In my research we aimed to assess gastrointestinal VRE carriage rates in two periods 
in 2016 and found rates of 2.2% with the same screening medium used in routine culturing and 
5.8% with enrichment broth. 
Medical records of 93 VRE carriers were analyzed; 24.7% of their routine culturing 
revealed absence of coliform bacterial normal flora. 18 were C. difficile positive but only 12 
(66.7%) received vancomycin therapy. 17 VRE carriers received vancomycin but did not have 
a history of C. difficile positivity. The association between C. difficile positivity and VRE 
colonization was statistically significant (p=0.0345) likewise in other studies. The chance of 
VRE positivity is 2.55 times higher in CDI patients. In vancomycin receiving patients the 
chance of VRE positivity is 13.59 times higher than in case of no vancomycin therapy. In 
   
conclusion, there is a 5.39 higher chance of becoming a VRE carrier after vancomycin therapy 
than after C. difficile infection. 
Compared to previous reports we also found malignancy as the most prevalent 
underlying disease (22.6%) in VRE carrier. In 21.5% of our VRE carriers there wasn’t any other 
underlying disease documented in their medical history than a diagnosis related to infectious 
origin. It is obvious that infections have great impact on hospital stay and the chosen antibiotic 
therapy. Longer hospitalization results in extended antibiotic consumption and only 21.5% of 
the carriers did not receive any antibiotics. The anti-anaerobic drug metronidazole was the most 
commonly administered (47.3%) followed by cephalosporins (40.9%). 31.2% of carriers 
received vancomycin which was the fourth most commonly administered drug together with 
carbapenems. 
In one interesting case the patient colonized with vanA E. hirae had previously vanA E. 
faecium isolated from his stool one month before. We assume that transfer of the vanA gene 
might have occurred between the two species, although we did not confirm this hypothesis with 
molecular methods. Overall, we detected 37.3% vanA VRE which is alarming since vanA can 
be transmitted to other nosocomial pathogens from a different genus such as Staphylococcus 
aureus. 
Our intestinal VRE isolates were found to be sensitive to newer agents. Only 4 out of 5 
E. faecalis isolates were resistant to quinupristin-dalfopristin (Q/D). Although, Enterococcus 
faecalis is intrinsically resistant to Q/D because of the expression of the lsa gene, clinical 
isolates with nonsense mutations in this gene can be susceptible. 
Prevalence of colonization with VRE reported by several studies is difficult to compare 
due to the differences in the target population, sample types, detection methods using different 
media and/or glycopeptide concentrations. D’Agata and colleagues published that rectal swab 
failed to detect a large proportion of patients with gastrointestinal colonization. Therefore we 
decided to use stool samples in our study. Several articles have documented that broth 
enrichment enhances the detection rates. The limitation of our study was the investigation of 
two periods with two different methods, so direct comparison of solid medium and enrichment 
broth could not be carried out. Although more VRE have been identified with broth enrichment, 
the use of solid Screen is less labor-intensive and time-consuming, and therefore easier to 
implement in routine diagnostics. 
  
   
SUMMARY 
 
The aim of our surveillance study was to characterize and elicit the genetic relatedness 
of VRE isolated from clinical samples and to determine the carriage rate of VRE in stool 
samples. We also investigated various risk factors which could be associated with VRE 
colonization. 
Between 2012 and 2015 we determined the presence of 40 VanB and 3 VanA E. faecium 
isolates. Fortunately, all of them were susceptible to newer antibiotics such as linezolid, 
tedizolid, tigecyclin and daptomycin. According to MLST all of the tested isolates belonged to 
clonal complex 17 (CC17), a specific lineage associated with nosocomial E. faecium strains. 
We also reported VREfm isolates belonging to ST412 and ST364 sequence types for the first 
time from the Central European region. PFGE revealed 9 different pulsotypes. 74% of the 
strains could be grouped into 3 main clusters (ENTCO-062, ENTCO-075, ENTCO-151) 
indicating monoclonality. Although 5 isolates showed 100% similarity within the ENTCO-062 
cluster (with ST17 and vanB genotype) these proved to be sporadic cases.   
We showed the presence of fecal carriage of VRE in the Eastern region of Hungary. 
Stool colonization proved to be 2.2% with solid screening medium but 5.8% with enrichment 
broth. Finding similar species and similar rates of vanA and vanB strains in stool VRE compared 
to clinical VRE might indicate the stool origin of the latter. Interestingly we found a high rate 
of fecal carriage of E. gallinarum which was present in clinical samples only till 2009 and was 
subsequently replaced by more resistant vanA/vanB strains. 
In view of our findings we suggest limiting the inadequate use of antibiotics inefficient 
against enterococci and advise the screening of risk groups such as patients with malignancy, 
diabetes, history of recent hospitalization or former C. difficile infection. Fortunately, there was 
no outbreak during the investigation period but constantly high prevalence of MRSA and the 
increasing rate of C. difficile infections in Hungary can potentially lead to the increased use of 
vancomycin. Therefore we can expect the further rise of VRE especially in the nosocomial 
setting. Emergence of VREfm emphasizes the need for the application of stringent control 
measures to decrease the risk of dissemination of the resistant bacteria such as isolation of 
infected/colonized patients, increased environmental cleaning and improved antimicrobial 
interventions. 
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